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Background: We investigated the usefulness of inﬂammatory markers including the delta neutrophil
index (DNI), erythrocyte sedimentation rate, C-reactive protein, and procalcitonin as early predictors of
sepsis in patients with acute prostatitis (AP). In addition, we evaluated the efﬁcacy of intermittent
catheterization for the initial management of acute urinary retention (AUR) in patients with AP.
Materials and methods: All patients who presented to the emergency department and were admitted
to the urology department from January 2011 to December 2013 were retrospectively reviewed. The
clinical features, prostate-speciﬁc antigen levels, inﬂammatory marker levels, and urine and blood cul-
ture results were obtained from medical records. Patients who underwent urethrocystoscopy or prostate
biopsy within 7 days were excluded.
Results: Of 132 patients (mean age, 64.8 years) in this cohort, 17 (12.9%) had sepsis and 22 (16.7%) had
positive blood cultures. Escherichia coli was the most common isolate in blood and urine cultures. In
multivariate analysis, the DNI and prostate-speciﬁc antigen were identiﬁed as predictors of sepsis. The
DNI was a signiﬁcant prognostic factor for bacteremia. In patients with AP, procalcitonin was not a
signiﬁcant predictor of sepsis. Of 19 patients with AUR, 10 needed Foley catheterization because of re-
fractory AUR. C-reactive protein was a signiﬁcant predictor of failure of the initial management of AUR.
Conclusions: The DNI is useful as a predictive factor for sepsis and bacteremia in patients with AP.
Without mandatory cystostomy, intermittent catheterization could be one of the useful management
options of AUR in patients with AP.
© 2018 Asian Paciﬁc Prostate Society, Published by Elsevier Korea LLC. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute prostatitis (AP) is a common and clinically important
genitourinary infection. AP is characterized by acute inﬂammation
of prostatic tissues and presents symptoms similar to those of
lower urinary tract infection. Escherichia coli is the predominant
pathogen in AP.1 Ascending urethral infection and intraprostatic
reﬂux are believed to be the main causes of AP.2 Acute urinaryinary retention; BPH, benign
delta neutrophil index; ESR,
ostate Syndrome Score; PSA,
y response syndrome; WBC,
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te Society, Published by Elsevierretention (AUR) can increase the risk of bacteremia and can prog-
ress to a serious infection such as sepsis in patients with AP.
Therefore, it is generally recommended that patients with AP with
AUR undergo mandatory suprapubic catheterization to avoid
bacteremia and pain associated with Foley catheterization.3,4
However, in practice, intermittent catheterization seems to be
used as an initial management with no clinical evidence of its
beneﬁt.2
Patients who are suspected to have inﬂammatory disease or
serious infection may undergo a diagnostic workup that involves
multiple laboratory tests. Erythrocyte sedimentation rate (ESR) and
C-reactive protein (CRP) level are among the most widely used
diagnostic markers in detecting inﬂammatory conditions.5 The
European Association of Urology recommended procalcitonin level
as a useful marker for predicting the development of systemic in-
ﬂammatory response syndrome (SIRS) and differentiating between
infectious and noninfectious causes of severe inﬂammatory status.4Korea LLC. This is an open access article under the CC BY-NC-ND license (http://
Prostate International 6 (2018) 157e161158Recently, the serum delta neutrophil index (DNI) has been sug-
gested as a new inﬂammatory marker for the early prediction of
sepsis.6-8 However, to the best of our knowledge, no study has
evaluated the efﬁcacy of biomarkers such as ESR, CRP, DNI, and
procalcitonin to guide treatment decisions in patients with AP.
Because AP related to transrectal prostate biopsy is becoming
more common, data are lacking on the pathogens andmanagement
of patients with AP without prior biopsy.3 The aim of this study was
to compare the efﬁcacy of inﬂammatorymarkers as early predictors
of sepsis in patients with AP without a prior biopsy. Furthermore,
we introduce our experience with intermittent catheterization as
the initial management in patients with AP with AUR.
2. Materials and methods
This retrospective observational study was approved by the
institutional review board, which allowed collecting data on all pa-
tients with AP treated at our institution. Clinical variables relevant to
the study included age, initial vital signs, symptoms, ﬁndings on
abdominal physical examination, prostate-speciﬁc antigen (PSA)
level, inﬂammatorymarkers includingwhite blood cell (WBC) count,
ESR, CRP level, DNI, procalcitonin level, and urine and blood culture
results, antimicrobial susceptibility results, period of antibiotics use,
and voiding patterns after the initial management for AUR.
2.1. Patients
Patients with AP who were admitted to the urology department
of a tertiary hospital from January 2011 to December 2013 were
initially reviewed. AP was diagnosed according to clinical features
(fever, painful voiding, or a painful sensation during digital rectal
examination) and the results of laboratory tests. Patients with a
hematologic disorder, those discharged against medical advice,
those with other causes of urinary tract infection including acute
pyelonephritis and sexually transmitted infection, those with pro-
cedures including urethrocystoscopy or prostate biopsy within
7 days, and those with a history of prostate cancer at the time of
diagnosis were excluded.
2.2. Management protocol for AUR
According to the management protocol at our institution for all
patients suspected to have AUR, the initial evaluation consists of
residual urine check with a bladder scan (BVI-3000 BladderScan;
Verathon Inc., Bothell, WA, USA). AUR was deﬁned as a postvoid
residual urine volume of >300mL or incomplete bladder emptying.
The primary treatment for AUR has been intermittent catheteri-
zation. Foley catheterization was performed in patients with sub-
sequent AUR after intermittent catheterization for 2 days.
Cystostomy was not considered as one of the initial management
options.
2.3. Outcomes
Sepsis was deﬁned as activation of the inﬂammatory process
due to infection.9,10 SIRS was deﬁned based on two or more of the
following conditions: (1) body temperature >38C or <36C; (2)
heart rate >90 beats/min; (3) respiratory rate >20 breaths/min or
PaCO2<32mmHg; and (4)WBC >12,000 cells/mm3 or<4,000 cells/
mm3 or >10% immature (band) forms.
2.4. Statistical analysis
Continuous variables are expressed as median (interquartile
range). Categorical variables are reported as the number ofoccurrences and frequency. Student t test and Pearson's Chi-square
test were used for statistical comparisons of continuous and cate-
gorical variables, respectively. Simple and multiple logistic regres-
sion analyses with a forward stepwise procedure were used. The
area under the receiver operator characteristic curve was used to
determine the optimal cutoffs of DNI for predicting bacteremia and
sepsis. All statistical comparisons were conducted using IBM SPSS
Statistics, version 23 (IBM Corporation, Armonk, NY, USA). A P value
<0.05 was considered to indicate a statistically signiﬁcant
difference.
3. Results
Table 1 presents the baseline characteristics of patients with AP.
In 132 patients (median age, 64.8 years) with AP, feverwas themost
common initial symptom (n ¼ 108, 81.8%), followed by dysuria and
chills. AUR was found in nine of 24 (37.5%) patients with a sense of
voiding failure at the initial diagnosis. Positive blood culture results
revealed 30 bacterial species in 22 (16.7%) patients. E. coli (n ¼ 19,
63.3%) was the most common isolate. Staphylococcus (n ¼ 6, 20.0%)
and Klebsiella (n ¼ 4, 13.3%) species were also reported. Of 106
bacterial species in 95 patients with positive urine culture results,
E. coli was also the most common isolate (n ¼ 53, 50.0%).
The patients were divided into two groups according to the
presence or absence of sepsis. A lower PSA level and higher heart
and respiratory rates were found in patients with sepsis (P ¼ 0.001,
P ¼ 0.013, P < 0.001, respectively). No signiﬁcant differences were
found in the initial symptoms and laboratory values includingWBC,
ESR, CRP level, DNI, and procalcitonin level.
In simple logistic regression analysis, CRP level, procalcitonin
level, PSA level, and DNI were identiﬁed as risk factors for sepsis. In
multiple logistic regression analysis, DNI [odds ratio (OR) ¼ 1.21
(1.034e1.407), P ¼ 0.017] and PSA level [OR ¼ 0.95 (0.906e0.998),
P ¼ 0.040] were signiﬁcantly associated with the predictors of
sepsis. ESR, CRP level, procalcitonin level, and previous Foley
insertion status were not signiﬁcant predictors of sepsis (Table 2).
In multivariate analysis for predicting bacteremia, DNI
[OR ¼ 1.15 (1.000e1.318), P ¼ 0.049] and previous Foley insertion
status [OR ¼ 3.46 (1.161e9.289), P ¼ 0.001] were considered as
predictive factors (Table 3).
Of 19 patients with AUR during admission [initial diagnosis
(n ¼ 9), delayed onset (n ¼ 10)], 10 needed Foley catheterization
because of refractory AUR after intermittent catheterization for
2 days. There was no signiﬁcant difference in the basic character-
istics between patients with and without a need for Foley cathe-
terization. A CRP level >257 mg/L [OR ¼ 1.73 (1.045e3.071),
P ¼ 0.043] was a signiﬁcant predictor of failure of intermittent
catheterization for 2 days.
4. Discussion
This is the ﬁrst report to identify the efﬁcacy of inﬂammatory
markers includingWBC, ESR, CRP level, procalcitonin level, and DNI
for predicting the presence of sepsis in patients with AP. We found
that the predictive value of DNI was higher than that of other in-
ﬂammatory markers including ESR, CRP level, and procalcitonin
level. In addition, intermittent catheterization was safe and useful
for the initial management of AUR in patients with AP, contrary to
the long-standing belief that suprapubic catheterization is
mandatory.
The most common cause of AP is assumed to be reﬂux of
infected urine from the urethra into the prostate.11 Previous studies
reported E. coli as the causative pathogen in 50e80% of cases.12 In
this study, E. coli was the most common isolate in urine cultures
(50.0%) and blood cultures (63.3%). However, the diagnostic and
Table 1
Baseline characteristics of patients with acute prostatitis.
Total Sepsis (þ) Sepsis () P
No. patients 132 17 (12.9) 115 (87.1)
Age (years) 64.8 (53.9e76.3) 75.9 (55.3e78.4) 62.9 (53.0e72.8) 0.271
Body mass index (kg/m2) 24.2 (22.2e25.5) 24.0 (21.8e26.7) 24.2 (22.3e25.5) 0.951
Prostate volume (cm3) 39.4 (30.4e54.3) 31.2 (27.6e47.5) 40.7 (30.6e54.9) 0.177
Initial symptom
Fever 108 (81.8) 15 (88.2) 92 (80.0) 0.458
Dysuria 93 (70.5) 9 (52.9) 84 (73.0) 0.648
Chills 92 (69.7) 15 (88.2) 76 (66.1) 0.987
Myalgia 30 (22.7) 3 (17.6) 26 (22.6) 0.573
Sense of voiding failure 24 (18.2) 3 (17.6) 21 (18.3) 0.939
Initial laboratory values
WBC (103/mL) 15.5 (10.5e19.0) 15.6 (11.1e18.9) 15.4 (10.4e19.0) 0.803
ESR (mm/h) 34.5 (15.0e62.5) 40.5 (21.5e76.5) 34.0 (14.0e60.0) 0.363
CRP (mg/L) 117.3 (32.1e162.6) 113.8 (31.1e170.4) 131.1 (113.8e170.4) 0.194
DNI 2.3 (0.4e3.9) 3.5 (0.8e6.1) 2.2 (0.4e3.8) 0.088
Procalcitonin (ng/mL) 4.9 (0.6e34.8) 16.6 (9.2e63.9) 0.9 (0.3e18.5) 0.209
PSA (ng/mL) 14.2 (6.3e31.8) 7.05 (5.01e10.97) 16.8 (6.5e36.3) 0.001
Blood culture (þ) 22 (16.7) 17 (100.0) 5 (4.3) <0.001
Urine culture (þ) 95 (72.0) 14 (82.4) 81 (70.4) 0.307
No. meeting sepsis criteria
Heart rate 56 (42.4) 12 (70.6) 44 (38.3) 0.013
Respiratory rate 9 (6.8) 16 (94.1) 68 (59.1) <0.001
Body temperature or PaCO2 84 (63.6) 3 (17.6) 6 (5.2) 0.221
WBC 89 (67.4) 12 (70.6) 76 (66.1) 0.750
Period of antibiotics use 15.0 (13.0e17.0) 17.0 (16.0e18.0) 15.0 (13.0e17.0) 0.031
Data are n (%) or median (interquartile range).
CRP, C-reactive protein; DNI, delta neutrophil index; ESR, erythrocyte sedimentation rate; PSA, prostate-speciﬁc antigen; WBC, white blood cells.
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The positive urine culture rate in patients with AP was 30e66%.
Lee et al investigated a series of 144 patients with AP and found a
positive urine culture in only 51 patients (35.4%).15 Nagy and Kubej
found a positive rate of 66.2% in 347 patients.12 These results are
similar to our ﬁnding of a 72.0% positive urine culture result in
patients with AP. Etienne et al performed a retrospective analysis of
347 patients with AP and found that 21% had positive blood cul-
tures.16 A body temperature of >38.4C at admission and the fever
duration were predictive of a positive blood culture. In this study,
16.7% of patients showed positive blood culture results. The DNI
and previous Foley insertion status were the predictive factors of
bacteremia.
The DNI reﬂects the number of immature granulocytes in pe-
ripheral blood.17 Polymorphonuclear neutrophil granulocytes
function as the host defense against bacteria. After maturation, they
migrate into peripheral blood.18 The presence of immature gran-
ulocytes represents increased myeloid cell production, generally
accompanied by infection or severe inﬂammatory disease.19 The
level of immature granulocytes is one of the criteria for the deﬁ-
nition of SIRS.10 However, immature granulocytes can be counted
using a manual methodwith blood ﬁlmmorphology, which has not
been widely used.19 An automatic analyzer measures differential
leukocyte counts by using cytochemical myeloperoxidase reaction
or light beam reﬂection from nuclear lobularities in WBCs. The DNI
is deﬁned as the difference in counts between the two methods.20
Several recent studies have evaluated the DNI as a diagnostic and
prognostic marker of sepsis.20e22 Compared with other promising
inﬂammatory markers such as ESR, CRP level, and procalcitonin
level, the DNI is a useful marker of early sepsis and a positive blood
culture in patients with AP. The present data supported the ﬁndings
that DNI increase becomes higher as the infection becomes more
severe. In an additional analysis to determine the optimal cutoffs
for predicting bacteremia, a DNI cutoff of 5.4 was determined,
similar to that of previously published studies.23e25
Generally, ESR and CRP are themost widely usedmarkers for the
early detection of sepsis. However, ESR has a limited role in earlysepsis detection as it is associated with the late reaction in acute
inﬂammatory disease. CRP reﬂects the severity of inﬂammation
before 1e3 days.26 In this study, CRPmeasured at the time of visit to
our institution was not identiﬁed as a predicting factor. Interest-
ingly, CRP at 2e3 days after treatment was a signiﬁcant factor for
predicting sepsis in the univariate analysis (OR ¼ 1.01, P ¼ 0.032).
However, this result was not suitable for identifying the early
predictors of sepsis. Moreover, our study found that procalcitonin,
known as an early predictive marker for bacteremia and sepsis, has
no effect on the early prediction of sepsis and bacteremia in pa-
tients with AP. Compared with other markers, the DNI can be easily
calculated using complete blood count, which is performed as a
basic test in patients with suspected infection or sepsis without
further examination.
PSA, although generally used in practice as the novel serum
marker that revolutionized the early detection and management of
prostate cancer, can be elevated owing to several reasons including
infection, recent instrumentation, ejaculation, trauma, or voiding
difﬁculty.27,28 In previous studies, PSA was usually found to be
elevated in AP but is not indicated in the workup.3,11 However, at
our institution, we have routinely measured PSA level in patients
who developed AP. In comparing patients with AP according to the
occurrence of sepsis, we found that a lower PSA level was
frequently present in sepsis. We assumed that considering that PSA
elevation is related to damage of the prostatic structure, lower PSA
levels were more frequently observed in cases with hematogenous
dissemination of bacterial infection after the damage of peripro-
static structures.
The diagnosis of AP is determined based on the clinical symp-
toms. The common symptoms of AP include pain in the lower
abdomen, rectum, and perineum. Acute symptoms of urinary tract
infection, including dysuria and frequency, are accompanied by
systemic symptoms of fever, chills, and malaise.13 AUR occurs in
approximately one in 10 patients with AP.28 Cystostomy has been
considered important in clearing the infection and providing pain
relief. Furthermore, cystostomy may prevent chronic infection.29,30
Therefore, several studies reported that 7e48% of patients with AUR
Table 2
Univariate and multivariate analyses for the prediction of sepsis.
Univariate analysis Multivariate analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age 1.02 (0.984e1.059) 0.271
Body mass index 0.99 (0.823e1.200) 0.950
Prostate volume 0.96 (0.911e1.017) 0.179
WBC 1.00 (1.000e1.000) 0.801
ESR 1.01 (0.990e1.029) 0.361
CRP 1.00 (0.998e1.009) 0.198
DNI 1.20 (1.048e1.379) 0.009 1.21 (1.034e1.407) 0.017
Procalcitonin 1.03 (0.984e1.074) 0.220
PSA 0.95 (0.911e0.999) 0.009 0.95 (0.906e0.998) 0.040
Previous Foley insertion status 4.29 (1.426e12.893) 0.010 2.79 (0.816e9.515) 0.102
CI, conﬁdence interval; CRP, C-reactive protein; DNI, delta neutrophil index; ESR, erythrocyte sedimentation rate; PSA, prostate-speciﬁc antigen; WBC, white blood cells.
Table 3
Univariate and multivariate analyses for the prediction of bacteremia.
Univariate analysis Multivariate analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age 1.02 (0.986e1.052) 0.271
Body mass index 0.94 (0.801e1.109) 0.476
Prostate volume 1.00 (0.971e1.026) 0.904
WBC 1.00 (1.000e1.000) 0.643
ESR 1.01 (0.993e1.030) 0.232
CRP 1.00 (0.998e1.008) 0.258
DNI 1.13 (1.000e1.286) 0.049 1.15 (1.000e1.318) 0.049
Procalcitonin 1.09 (0.982e1.211) 0.106
PSA 0.98 (0.961e1.008) 0.199
Previous Foley insertion status 3.27 (1.194e8.932) 0.001 3.46 (1.161e9.289) 0.001
CI, conﬁdence interval; CRP, C-reactive protein; DNI, delta neutrophil index; ESR, erythrocyte sedimentation rate; PSA, prostate-speciﬁc antigen; WBC, white blood cells.
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terization is an easier option for relieving obstruction.3 In this
study, 14.3% of patients with AP experienced AUR, and 52.6% of
those were treated with Foley catheterization because of refractory
AUR after intermittent catheterization for 2 days. Although we did
not compare the efﬁcacy of intermittent catheterization with that
of cystostomy as the initial management in patients with AP with
AUR, we found no severe complication events in this cohort;
therefore, we conclude that intermittent catheterization could be
one of the useful management options for AUR in patients with AP.
The present study had several limitations including its retro-
spective design and the small number of patients owing to the low
incidence of AP. First, this study conﬁrms that the DNI is a signiﬁ-
cant predictor of bacteremia and sepsis in patients with AP. How-
ever, the deﬁnition of sepsis has recently changed.31 Therefore,
additional studies evaluating the efﬁcacy of the DNI as an early
predictor in the new criteria for sepsis are needed. Second,
although we found that intermittent catheterization in patients
with AP with AUR is a safe initial management option, the long-
term effects of intermittent catheterization remain unclear.
Because, until now, intermittent catheterization was not an initial
management option in patients with AP, little data have been
accumulated. According to the results of this study, if intermittent
catheterization is considered an option in the management of AP,
more data will be accumulated for elucidating the long-term efﬁ-
cacy of intermittent catheterization.
Finally, we were unable to assess the inﬂuence of usual urina-
tion symptoms by using uroﬂowmetry and symptom scoring, such
as the International Prostate Syndrome Score, before AP. Although
most patients were assessed for recalled International Prostate
Syndrome Score, this information was not used in the analysis for
accuracy of data. Moreover, some patients were treated withbenign prostatic hyperplasia (BPH) medications before AP. As pa-
tients treated with BPH medications and those without BPH may
have different predictors for sepsis, we plan to conduct additional
studies in the future.5. Conclusions
In patients with AP, the DNI was a signiﬁcantly useful marker for
predicting early sepsis. Intermittent catheterization could be one of
the useful management options for AUR in patients with AP instead
of cystostomy.Conﬂicts of interest
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